The Discrepancy of ABI and CAVI Values for Arterial Stiffness Evaluation
Asploro Journal of Biomedical and Clinical Case Reports · 21.04.2026 · 1
DOI: 10.36502/2026/accrr.6107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asploro Journal of Biomedical and Clinical Case Reports, online erschienen am 21.04.2026. Verfasst von Hiroshi Bando und 4 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The current case is a 57-year-old male who had no history of cardiovascular, hypertensive, renal, diabetic, or lipid problems, with a BMI of 24.7 kg/m². He underwent pulse wave velocity (PWV) measurement, with results showing a cardio–ankle vascular index (CAVI) of 11.1/10.7 and an ankle–brachial index (ABI) of 0.98/1.31 (right/left), respectively. The inter-limb difference of 0.33 in ABI exceeded the standard threshold for clinically significant asymmetry. The case remained asymptomatic and showed no clinical signs of peripheral arterial disease (PAD). Because of the discrepancy between ABI and CAVI values, further interpretation of the vascular indices was considered necessary to determine their potential clinical significance.
Zitieren
APA
Bando, H., Okada, M., Ogawa, T., Iwatsuki, N., & Sakamoto, K. (2026). The Discrepancy of ABI and CAVI Values for Arterial Stiffness Evaluation. Asploro Journal of Biomedical and Clinical Case Reports, 1. https://doi.org/10.36502/2026/accrr.6107
Vancouver
Bando H, Okada M, Ogawa T, Iwatsuki N, Sakamoto K. The Discrepancy of ABI and CAVI Values for Arterial Stiffness Evaluation. Asploro Journal of Biomedical and Clinical Case Reports. 2026:1. doi:10.36502/2026/accrr.6107
BibTeX
@article{Bando2026,
author = {Bando, Hiroshi and Okada, Masaki and Ogawa, Tomoya and Iwatsuki, Noboru and Sakamoto, Kazuki},
title = {The Discrepancy of ABI and CAVI Values for Arterial Stiffness Evaluation},
journal = {Asploro Journal of Biomedical and Clinical Case Reports},
year = {2026},
pages = {1},
doi = {10.36502/2026/accrr.6107}
}
EUVIMED